EQUISUL-SDT® is indicated for the treatment of lower respiratory tract infections in horses caused by susceptible strains of Streptococcus
equi subsp. zooepidemicus. EQUISUL-SDT® is produced using Aurora Pharmaceutical’s patented drug product formulation. The product
demonstrated 20% increased bioavailability over an existing paste product in a pharmacokinetic crossover study.
- Safety was demonstrated in a controlled study in horses at 1X, 3X and 5X the recommended dose for 30 days
- Low incidence of side effects in controlled safety studies
- Easy-to-use, apple-flavored liquid formulation
- Significantly higher bioavailability on a mg-to-mg basis compared to an approved paste product, based on a pharmacokinetic crossover study
Related Documents
AUR3020
Equisul-SDT 400mg/ml 560ml
/PennVet Catalog/TX - Product Categories/67 - Pharmaceuticals/105 - Oral Pharmaceuticals/3 - Antibiotics/3 - Liquids & Suspensions/2 - Veterinary Labeled
/PennVet Catalog/TX - Manufacturers/AURORA - Aurora Phamaceutical
Product Detail Page